MPMichael H. Perskin

Michael H. Perskin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael H. Perskin has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Colleen Gillespie

    New York University Grossman School of Medicine

    3 shared publications
  • Judith D. Goldberg

    Division of Biostatistics, Department of Population Health NYU Grossman School of Medicine New York New York USA

    3 shared publications
  • Lisa Park

    Department of Ophthalmology (Z.P.E., E.J.C., E.C., I.H., J.J.J., L.P.), Division of Biostatistics and Department of Population Health (J.D.G., X.L., M.H.P.), and Division of General Internal Medicine and Department of Medicine (C.G., S.Z.), New York University School of Medicine, New York, NY

    3 shared publications
  • Xiaochun Li

    Department of Ophthalmology (Z.P.E., E.J.C., E.C., I.H., J.J.J., L.P.), Division of Biostatistics and Department of Population Health (J.D.G., X.L., M.H.P.), and Division of General Internal Medicine and Department of Medicine (C.G., S.Z.), New York University School of Medicine, New York, NY

    3 shared publications
  • Zachary Elkin

    Department of Ophthalmology, NYU Grossman School of Medicine, NYU Langone Health, 222 E 41st St, 3rd and 4th Floors, New York, NY, 10017, USA

    3 shared publications
  • Elisabeth J. Cohen

    Department of Ophthalmology, New York University School of Medicine, New York, New York

    2 shared publications

Latest Publications

  • Open Access

    The Case for Mobility Assessment in Hospitalized Older Adults: American Geriatrics Society White Paper Executive Summary

    by Heidi L. Wald, Ravishankar Ramaswamy, Michael H. Perskin, Lloyd Roberts, Michael Bogaisky, Winnie Suen, Anna Mikhailovich, for the Quality and Performance Measurement Committee of the American Geriatrics Society

    Mobility can be defined as the ability to move or be moved freely and easily. In older adults, mobility impairments are common and associated with risk for additional loss of function. Mobility loss is particularly common in these individuals during acute illness and hospitalization, and it is associated with poor outcomes, including loss of muscle mass and strength, long hospital stays, falls, declines in activities of daily living, decline in community mobility and social participation, and nursing home placement. Thus, mobility loss can have a large effect on an older adult's health, independence, and quality of life. Nevertheless, despite its importance, loss of mobility is not a widely recognized outcome of hospital care, and few hospitals routinely assess mobility and intervene to improve mobility during hospital stays. The Quality and Performance Measurement Committee of the American Geriatrics Society has developed a white paper supporting greater focus on mobility as an outcome for hospitalized older adults. The executive summary presented here focuses on assessing and preventing mobility loss in older adults in the hospital and summarizes the recommendations from that white paper. The full version of the white paper is available as Text S1. J Am Geriatr Soc 67:11–16, 2019.


  • Evaluating Physician Attitudes and Practices Regarding Herpes Zoster Vaccination

    by Edmund Tsui, Colleen Gillespie, Michael Perskin, Sondra Zabar, Mengfei Wu, Elisabeth J. Cohen

    Purpose: To investigate the knowledge, attitudes, and practice patterns of primary care physicians regarding administration of the herpes zoster (HZ) vaccine at NYU Langone Health (NYULH). Methods: A cross-sectional online survey was distributed from January to March 2017 to all physicians in the Division of General Internal Medicine and Clinical Innovation at NYULH across 5 different practice settings. Results: The response rate was 26% (138 of 530). Of the surveyed physicians, 76% (100/132) agreed that the HZ vaccine was an important clinical priority, compared with 93% and 94% for influenza and pneumococcal vaccination, respectively (P < 0.001). Only 35% (47/132) strongly agreed that it was important, compared with 68% (90/132) and 74% (98/132) who strongly agreed that pneumococcal and influenza vaccines, respectively, were important. Respondents estimated that 43% of their immunocompetent patients aged 60 or older received the HZ vaccine, whereas only 11% of patients aged 50 to 59 received the HZ vaccine (P < 0.001). The rate of HZ vaccination was lower in public hospitals (26%) than in the NYULH faculty group practice (46%) (P = 0.007). A greater percent (67% and 72%) of their patients have received influenza and pneumococcal vaccines, respectively (P < 0.001). Almost all doctors (99%, 131/132) consider the Centers for Disease Control and Prevention recommendations important in determining vaccination practices. Conclusions: HZ vaccination rates remain relatively low compared with rates of influenza and pneumonia vaccination. The recommendation for vaccination against zoster by the Centers for Disease Control and Prevention for individuals aged 50 years and older and stronger recommendations by primary care physicians for administration of zoster vaccines are needed to increase HZ vaccination rates.


  • Improving Care Using a Bidirectional Geriatric Cardiology Consultative Conference

    by Eleonore V. Grant, Adam H. Skolnick, Joshua Chodosh, Michael H. Perskin, Nicole M. Orr, Caroline Blaum, John A. Dodson

    More than 13 million persons in the United States aged 65 and older have cardiovascular disease (CVD), and this population is expected to increase exponentially over the next several decades. In the absence of clinical studies that would inform how best to manage this population, there is an urgent need for collaborative, thoughtful approaches to their care. Although cardiologists are traditionally regarded as leaders in the care of older adults with CVD, these individuals have multiple comorbidities, physiological differences, and distinct goals of care than younger patients that require a specialized geriatric lens. Thus, collaboration is needed between geriatricians, cardiologists, and other specialists to address the unique needs of this growing population. Accordingly, clinicians at New York University Langone Health and School of Medicine established a monthly Geriatric Cardiology Conference to foster an integrative approach to the care of older adults with CVD by uniting specialists across disciplines to collaborate on treatment strategies. At each conference, an active case is discussed and analyzed in detail, and a consensus is reached among participants regarding optimal treatment strategies. The conference attracts faculty and trainees at multiple levels from geriatrics, cardiology, and cardiothoracic surgery. The model may serve as a paradigm for other institutions moving towards geriatric‐informed care of older adults with CVD.


  • Improving Adherence to National Recommendations for Zoster Vaccination Through Simple Interventions

    by Zachary P. Elkin, Elisabeth J. Cohen, Judith D. Sc.D. Goldberg, Xiaochun Li, Eliana B.A. Castano, Colleen Gillespie, Ilyse Haberman, Jesse J. Jung, Sondra Zabar, Lisa Park, et al.

    Objective: In 2011, 15.8% of eligible patients in the United States were vaccinated against herpes zoster (HZ). To increase the usage of the HZ vaccine by studying physicians' knowledge, attitudes, practices, and perceived obstacles after interventions to overcome barriers. Methods: General internal medicine physicians were surveyed with a cross-sectional internet survey from October to December 2011 before interventions to increase the use of the HZ vaccine and 1 year later. Interventions included education, increasing availability at the medical center pharmacy, and electronic medical record reminders. Outcome measures included changes in knowledge, attitudes, and practices, and perceived barriers. McNemar chi-square tests were used to compare the changes from the baseline survey for physicians who completed the follow-up survey. Results: Response rate for the baseline study was 33.5% (89/266) and for the follow-up was 29.8% (75/252). Fifty-five completed both surveys. There was a decrease from 57% at baseline to 40% at follow-up in the proportion of physicians who reported that less than 10% of their patients were vaccinated. They were more likely to know the HZ annual incidence (30% baseline; 70% follow-up; P=0.02), and report having educational information for physicians (7% baseline; 27% follow-up; P=0.003). The top helpful intervention was nursing administration of the vaccine. Average monthly HZ vaccine usage in the affiliated outpatient pharmacy increased in 10 months between surveys by 156% compared with the 3 months before the baseline survey. Conclusions: Interventions implemented during the study led to an increase in physicians' basic knowledge of the HZ vaccine and an increase in usage at the affiliated pharmacy.


  • Studying Physician Knowledge, Attitudes, and Practices Regarding the Herpes Zoster Vaccine to Address Perceived Barriers to Vaccination

    by Zachary Ba Elkin, Elisabeth J. Cohen, Judith D. ScD Goldberg, Colleen Gillespie, Xiaochun Li, Jesse Jung, Michael Cohen, Lisa Park, Michael H. Perskin

    Purpose: To increase usage of the herpes zoster (HZ) vaccine at an academic medical center by studying physicians' knowledge, attitudes, practices, and perceived barriers and analyze the findings by practice setting. Methods: A cross-sectional Internet-based survey administered to all 266 general internal medicine physicians in 4 clinical settings at an academic medical center between October 6 and December 12, 2011. Outcomes measures included knowledge questions regarding the disease and vaccine recommendations, Likert-type items about physician attitudes and practices, and questions about barriers and proposed interventions to improve utilization. Results: Response rate was 33.5% (89 of 266). Responders did not answer all questions. Only 66% (42 of 64) responded that HZ vaccination was an important clinical priority, and 48% (38 of 79) reported that less than 10% of their patients received the HZ vaccine. 95% responded that the influenza (61 of 64) and 92% that the pneumococcal (59 of 64) vaccines were important. Approximately 53% (42 of 79) and 51% (40 of 78) reported that more than 75% of their patients received these vaccines, respectively. Top barrier to vaccination was cost to patients (51 of 66; 77%). Lack of awareness of national recommendations (46 of 65, 71%) varied by setting. Physicians' preferred interventions included nurse-initiated prompting about vaccination (36 of 75, 48%) and chart reminders (34 of 74, 46%). Conclusions: Not only increased knowledge but also a change in attitudes and practice are needed to enhance implementation of national recommendations. To improve use of this vaccine, physicians including ophthalmologists need to recommend it more strongly.


  • Increasing Use of the Vaccine Against Zoster Through Recommendation and Administration by Ophthalmologists at a City Hospital

    by Jesse J. Jung, Zachary P. Elkin, Xiaochun Li, Judith D. Goldberg, Aimée R. Edell, Michael N. Cohen, Kevin C. Chen, Michael H. Perskin, Lisa Park, Elisabeth J. Cohen


  • Open Access

    Age-related changes in neutrophil structure and function

    by Michael H. Perskin, Bruce N. Cronstein